Author: ANHUSA

A new Trump administration rule will allow consumers to better understand the prices for hospital procedures. From the Washington Examiner: Hospitals will be required to post the prices they charge for surgeries and other medical procedures online under a new Trump administration rule… Previously, CMS required that hospitals make the information available to anyone who… Continue reading Healthcare Price Transparency Gets a Boost

The FDA is threatening homeopathy’s future. Here’s how we can save it. Action Alert! The FDA has proposed a new policy for regulating homeopathy—a policy which is a direct threat to many, many homeopathic medicines. To fully protect consumer access to these treatments, we need Congress to pass a law. Congress and the FDA have… Continue reading Can Homeopathy Be Saved?

An advisory committee is meeting to make recommendations to the FDA on whether or not to ban certain supplements from being made at specialized pharmacies. On September 12, the FDA’s advisory committee on compounded medicine—medicine made for individual patients at specialized pharmacies—will meet to discuss five ingredients: alpha lipoic acid, CoQ10, creatine monohydrate, pyridoxal 5 phosphate… Continue reading FDA to Ban More Supplements?